Article
A Database-Derived Global Overview of HCV Resistance-Associated Substitutions: Characterizing Genotypic, Regional, and Temporal Heterogeneity.
International journal of molecular sciences - 3 Jun 2026
Nunes Gabriela Tavares Marinho, Sant'Anna Thaís Barbosa Ferreira, de Araujo Natalia Motta
Abstract excerpt
Direct-acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) therapy, yet resistance-associated substitutions (RASs) remain a concern in specific clinical contexts. Here, we present a database-derived global overview of HCV RASs by analyzing 19,449 publicly available sequences across multiple genotypes and subtypes, encompassing both untreated and previously treated infections, in the NS3, NS5A,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
